Skip page top navigation FDA Logo--links to FDA home
page Logo of and Link to start page of Office of Regulatory Affairs, 
U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

IA#68-03   ---3/20/91


TYPE OF ALERT:  AUTOMATIC DETENTION

PRODUCT      :  CLENBUTEROL (ALL FORMS)

PRODUCT CODE :  6 8 Y I [-] 0 2

HARMONIZED
      CODE   :  UNKNOWN

PROBLEM      :  UNAPPROVED NEW ANIMAL DRUG: (DRAD)
                MAY LEAVE RESIDUE IN FOOD ANIMALS

COUNTRY      :  CANADA (CA, 260), ALL OTHER COUNTRIES

MANUFACTURER/
SHIPPER      :  ALL

MANUFACTURER/
SHIPPERS ID#  : N/A

CHARGE       :  "The article is subject to refusal of admission pursuant to
                section 801(a)(3) in that it appears to be a new animal drug
                which is unsafe within the meaning of Section 512
                [Adulteration, Section 501(a)(5)]."

RECOMMENDING
OFFICE       :  HFV-230/CVM
                Division of Compliance

REASON FOR
ALERT        :  The Center for Veterinary Medicine (CVM) has received
                information that "Clenbuterol," a drug that has not been
                approved in the United States, may be illegally imported from
                Canada, or other countries, for use in show beef cattle and
                other show livestock.  The drug is reported to have dramatic
                effects upon muscle development and as a repartitioning agent
                in altering the lean to fat ratio.  Recently, in Spain, there
                have been reports of acute poisoning of humans from their
                consumption of liver from clenbuterol-treated animals.

                Clenbuterol is approved in Canada as an injectable and in
                various oral dosage forms for use solely in horses.  The
                authorized source is Boehringer Ingelheim of Canada, under the
                trade name "Ventipulmin."  The manufacturer is
                Ingelheim-on-the-Rhine, in Germany.  The drug cannot be
                legally imported into the United States, except under an
                investigation exemption.  CVM has been informed but has not
                yet confirmed that veterinarians in the U.S. can obtain the
                drug from a Canadian source merely on the basis of a telephone
                call.  We do not know the mode of shipment or if the entries
                are formal, informal, or clandestine.  We do know, however,
                that the drug is in a gelatinous form packaged in bottles for
                encapsulating by the user, and is shipped to the United States
                in a form not approved in Canada.  The actual product
                containers or labels have not yet been seen by the Center.

INSTRUCTIONS :  Automatically detain all shipments of "Clenbuterol," in any
                form, unless the drug is imported under an approved INAD.
                Clenbuterol ("Ventipulmin") is usually or normally shipped
                from Canada, but may be shipped from other countries as well.
                Shipments may be directed to veterinarians or individuals.
                Because there are serious adverse public health implications
                when Clenbuterol is used in food-producing animals, this drug
                is inappropriate for release under the personal importation
                policy.

                Contact Ed Ballitch (CVM, 8-443-3336) when detentions are made
                under this Import Alert.

                Note: Import Alert 68-08 lists "Clenbuterol" among other
                drugs, but the context is different from this concern.

FOI          :  No purging required.


KEYWORDS      : CLENBUTEROL, UNAPPROVED NEW ANIMAL DRUG, IN FOOD ANIMALS,
                VENTIPULMIN, BOEHRINGER INGELHEIM, INGELHEIM-ON-THE-RHINE